P. Dias Wickramanayake

Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony‐stimulating factor and erythropoietin

Luisa Mantovani, Giuseppe Lentini, Bettina Hentschel et al. · British Journal of Haematology · 2000 · 102 citations · Full text

Medicine, Hematology, Pharmacotherapy +12

Favorable outcome of patients with relapsed or refractory Hodgkin’s disease treated with high-dose chemotherapy and stem cell rescue at the time of maximal response to conventional salvage therapy (Dexa-BEAM)

Andreas Josting, I. Katay, U. Rueffer et al. · Annals of Oncology · 1998 · 91 citations · Full text

Medicine, Hematology, Oncology +17

High-dose ifosfamide and mesna as continuous infusion over five days—a phase I/II trial

H. O. Klein, P. Dias Wickramanayake, Cl. Coerper et al. · Cancer Treatment Reviews · 1983 · 71 citations

Medicine, Pharmacology, Pharmacotherapy +9

Phase-II trial of idarubicin, fludarabine, cytosine arabinoside, and filgrastim (Ida-FLAG) for treatment of refractory, relapsed, and secondary AML

H. Tilman Steinmetz, Armin Schulz, Peter Staib et al. · Annals of Hematology · 1999 · 64 citations

Medicine, Pharmacology, Pharmacotherapy +16

Therapeutic effects of single-push or fractionated injections or continuous infusion of oxazaphosphorines (cyclophosphamide, ifosfamide, Asta Z 7557)

Hans Otto Klein, P. Dias Wickramanayake, Edith Christian et al. · Cancer · 1984 · 45 citations · Full text

Medicine, Oncology, Pharmacology +17